Is TGFBR1*6A Really Associated With Increased Risk of Cancer?
Authors:
- 20 October 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (30) , 7743-7744
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Int7G24A variant of the TGFBR1 gene and cancer risk: A meta-analysis of three case-control studiesLung Cancer, 2005
- Transforming growth factor β receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskGynecologic Oncology, 2005
- Combined Genetic Assessment of Transforming Growth Factor-β Signaling Pathway Variants May Predict Breast Cancer RiskCancer Research, 2005
- TGFBR1*6A is not associated with prostate cancer in men of European ancestryProstate Cancer and Prostatic Diseases, 2004
- No major association between TGFBR1*6A and prostate cancerBMC Genomic Data, 2004
- A phase II study of vinorelbine (VNR) and letrozole (LTZ) in aged women with metastatic breast cancer (MBC)Journal of Clinical Oncology, 2004
- Association Between TGFBR1*6A and Cancer: Is There Any Evidence?Journal of Clinical Oncology, 2004
- Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancersInternational Journal of Cancer, 2004
- TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control StudiesJournal of Clinical Oncology, 2003
- Novel inactivating mutations of transforming growth factor-? type I receptor gene in head-and-neck cancer metastasesInternational Journal of Cancer, 2001